Personalized Cancer Vaccines Market

Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patients particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.

Personalized Cancer Vaccines Market contains market size and forecasts of Personalized Cancer Vaccines in Global, including the following market information:

• Global Personalized Cancer Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Personalized Cancer Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

By Cancer Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Personalized Cancer Vaccines include Advaxis Inc, Personalis, Hoffmann-La Roche Ltd, BioNtech, Celldex, CureVac AG, Genetech, Genocea and Gritstone Oncology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Personalized Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Personalized Cancer Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Personalized Cancer Vaccines Market Segment Percentages, by Type, 2021 (%)

By Cancer Type

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Prostate Cancer
• Cervical Cancer
• Glioblastoma
• Others

By Mechanism of Action Type

• Tumor-associated antigens (TAAs)
• Tumor-specific antigens (TSAs)
• Somatic Mutations in Cancer Pharmacogenomics
• Pharmacogenomics towards Genomic Polymorphism

Global Personalized Cancer Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Personalized Cancer Vaccines Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Personalized Cancer Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Personalized Cancer Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Personalized Cancer Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Personalized Cancer Vaccines revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Advaxis Inc
• Personalis
• Hoffmann-La Roche Ltd
• BioNtech
• Celldex
• CureVac AG
• Genetech
• Genocea
• Gritstone Oncology
• ISA Pharmaceuticals
• Merck
• Moderna Therapeutics